Levy JA - Search Results

1

The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.

Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP. Killian MS, et al. Among authors: levy ja. AIDS Res Hum Retroviruses. 2006 Jul;22(7):640-7. doi: 10.1089/aid.2006.22.640. AIDS Res Hum Retroviruses. 2006. PMID: 16831088

2

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

3

Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.

Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA. Martinez-Mariño B, et al. Among authors: levy ja. AIDS. 2004 Oct 21;18(15):1991-9. doi: 10.1097/00002030-200410210-00003. AIDS. 2004. PMID: 15577620 Clinical Trial.

4

Potential herpesvirus interaction during HIV type 1 primary infection.

Lennette ET, Busch MP, Hecht FM, Levy JA. Lennette ET, et al. Among authors: levy ja. AIDS Res Hum Retroviruses. 2005 Oct;21(10):869-75. doi: 10.1089/aid.2005.21.869. AIDS Res Hum Retroviruses. 2005. PMID: 16225414

5

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Hare CB, et al. Among authors: levy ja. Clin Infect Dis. 2006 Mar 1;42(5):700-8. doi: 10.1086/500215. Epub 2006 Jan 23. Clin Infect Dis. 2006. PMID: 16447118

6

Killian MS, Fujimura SH, Hecht FM, Levy JA. Killian MS, et al. Among authors: levy ja. AIDS. 2006 Jun 12;20(9):1247-52. doi: 10.1097/01.aids.0000232231.34253.bd. AIDS. 2006. PMID: 16816552

7

Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy.

Sriram U, Wong M, Caillier SJ, Hecht FM, Elkins MK, Levy JA, Oksenberg JR, Baranzini SE. Sriram U, et al. Among authors: levy ja. AIDS Res Hum Retroviruses. 2007 May;23(5):741-7. doi: 10.1089/aid.2007.0209. AIDS Res Hum Retroviruses. 2007. PMID: 17531001 Clinical Trial.

8

CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Killian MS, Roop J, Ng S, Hecht FM, Levy JA. Killian MS, et al. Among authors: levy ja. J Clin Immunol. 2009 May;29(3):311-8. doi: 10.1007/s10875-009-9275-y. Epub 2009 Feb 3. J Clin Immunol. 2009. PMID: 19189205

9

Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Stranford SA, et al. Among authors: levy ja. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):597-602. doi: 10.1073/pnas.98.2.597. Epub 2001 Jan 2. Proc Natl Acad Sci U S A. 2001. PMID: 11136234 Free PMC article.

10

Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection.

Martinez-Mariño B, Ashlock BM, Shiboski S, Hecht FM, Levy JA. Martinez-Mariño B, et al. Among authors: levy ja. J Clin Immunol. 2004 Mar;24(2):135-44. doi: 10.1023/B:JOCI.0000019778.96564.26. J Clin Immunol. 2004. PMID: 15024180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters